FDA Approves Zynteglo for Patients with Beta-thalassemia Requiring Regular Blood Transfusions
August 17th 2022Zynteglo was approved for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions after safety and efficacy were demonstrated in clinical trials.
Read More
Addressing Language Barriers, Medication Therapy Management at Medicare Part D Outreach Clinics
August 17th 2022Rajul A. Patel, PharmD, PhD, director of the Medicare Part D Outreach Clinics at the University of the Pacific in Stockton, California, discusses his work providing drug savings advice to Medicare beneficiaries in diverse communities.
Watch
Oncology Overview: Treatment of Chronic Lymphocytic Leukemia with Ibrutinib, Venetoclax
August 16th 2022Both ibrutinib (Imbruvica) and venetoclax (Venclexta) carry an approved indication for use in chronic lymphocytic leukemia but do not often lead to complete remission, and therapy routinely continues indefinitely or until disease progression.
Read More